Sigilon Therapeutics, Inc. Share Price
Equities
SGTX
US82657L2060
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 13/08/18 | |
Director of Finance/CFO | 58 | 31/10/19 | |
Philip Johnson
PSD | President | 59 | 10/08/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 13/08/18 | |
Philip Johnson
PSD | President | 59 | 10/08/23 |
Gordon Brooks
BRD | Director/Board Member | - | 10/08/23 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |